Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Recent veterinary reviews summarize the epidemiologic risk factors and associated pathologies of feline overweight and obesity and emphasize that obese cats are 7 times more likely to develop diabetes and other metabolic disturbances. "Feline obesity is one of the most common yet least effectively treated health issues in veterinary medicine," Todd Zion, PhD, cofounder and CEO of Akston, said
Injections bypass the gut, ensuring the body utilizes the full dose
Research on similar GLP-1 peptides shows potency loss of 10-15% within the first month post-expiration, and potentially 30% or more within three months
Both candidates are designed to move beyond single-pathway GLP-1 therapy, but they take very different routes: CagriSema combines an amylin analog with semaglutide, while Retatrutide compresses GIP, GLP-1, and glucagon agonism into one investigational peptide
US$ 22.31
US$ 24.04
US$ 20.81
US$ 24.78
